Categories: News

Merus to Present at Canaccord Genuity’s 44th Annual Growth Conference

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will present at Canaccord Genuity’s 44th Annual Growth Conference on Tuesday, August 13, 2024 from 9:00-9:25 a.m. ET.

The webcast of the presentation will be contemporaneously available on the Investors page of the Company’s website. The archived presentation will also be available there for a limited time after the event.

About Merus
Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®. Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity. For additional information, please visit Merus’ website, X and LinkedIn.

Multiclonics®, Biclonics® and Triclonics® are registered trademarks of Merus N.V.

CONTACT: Investor and Media Inquiries:
Sherri Spear
Merus N.V.
SVP Investor Relations and Strategic Communications
617-821-3246
s.spear@merus.nl

Kathleen Farren
Merus N.V.
Assoc. Director IR/Corp Comms
617-230-4165
k.farren@merus.nl

Staff

Recent Posts

SOPHiA DDM™ Platform Certified Under IVDR

Regulatory milestone validates the SOPHiA DDM™ Platform as diagnostic tool in select markets BOSTON and ROLLE,…

47 mins ago

Novo Nordisk Foundation and Export and Investment Fund of Denmark press release: CEO appointed to lead Denmark’s AI supercomputer initiative

COPENHAGEN, Denmark, Aug. 14, 2024 /PRNewswire/ -- The Novo Nordisk Foundation and the Export and Investment…

47 mins ago

Bioz and InvivoGen Form Strategic Alliance to Accelerate Research Discovery and Efficiency

PALO ALTO, CA / ACCESSWIRE / August 14, 2024 / Bioz, Inc., a leader in…

47 mins ago

AmeriGuard Security Services, Inc. Awarded Prestigious Contract by U.S. Department of Veterans Affairs for Non-Emergency Medical Transportation Services for the Loma Linda Healthcare System

AmeriGuard Security Services, Inc. Transportation platform TransportUS, Inc., expands services with an additional new contract…

7 hours ago

IDEOlogy Health Ranks No. 717 on the 2024 Inc. 5000 Fastest-Growing Private Companies in America

NEW YORK, Aug. 13, 2024 /PRNewswire/ -- Inc. revealed today that IDEOlogy Health is No. 717…

7 hours ago